Have Questions?

History of Nitric Oxide

Literature

  1. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. The New England journal of medicine. 1993 Dec 30;329(27):2002-12.
  2. Stamler JS, Meissner G. Physiology of nitric oxide in skeletal muscle. Physiological reviews. 2001 Jan;81(1):209-37.
  3. Nathan C, Xie QW. Regulation of biosynthesis of nitric oxide. The Journal of biological chemistry. 1994 May 27;269(21):13725-8.
  4. Alderton WK, Cooper CE, Knowles RG. Nitric oxide synthases: structure, function and inhibition. Biochemical journal. 2001 Aug 1;357(3):593-615.
  5. Forstermann U, Sessa WC. Nitric oxide synthases: regulation and function. European heart journal. 2012 Apr 1;33(7):829-37.
  6. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. American Journal of Physiology-Cell Physiology. 1996 Nov 1;271(5):C1424-37.
  7. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proceedings of the National Academy of Sciences. 1987 Dec 1;84(24):9265-9.
  8. Garthwaite J, Charles SL, Chess-Williams R. Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. 1988 Jan;336(6197):385-8.
  9. Bredt DS, Hwang PM, Snyder SH. Localization of nitric oxide synthase indicating a neural role for nitric oxide. 1990 Aug;347(6285):768-70.
  10. Ignarro LJ, Napoli C, Loscalzo J. Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide: an overview. Circulation research. 2002 Feb 8;90(2):21-8.
  11. Hendgen-Cotta UB, Kelm M, Rassaf T. A highlight of myoglobin diversity: the nitrite reductase activity during myocardial ischemia-reperfusion. Nitric Oxide. 2010 Feb 15;22(2):75-82.
  12. Totzeck M, Hendgen-Cotta UB, Rammos C, Frommke LM, Knackstedt C, Predel HG, Kelm M, Rassaf T. Higher endogenous nitrite levels are associated with superior exercise capacity in highly trained athletes. Nitric Oxide. 2012 Aug 15;27(2):75-81.
  13. Totzeck, M.; Hendgen-Cotta, U.B.; Rassaf, T. Nitrite-Nitric Oxide Signaling and Cardioprotection. Adv Exp Med Biol 2017, 982, 335-346, doi:10.1007/978-3-319-55330-6_18.
  14. Rassaf, T.; Lauer, T.; Heiss, C.; Balzer, J.; Mangold, S.; Leyendecker, T.; Rottler, J.; Drexhage, C.; Meyer, C.; Kelm, M. Nitric oxide synthase-derived plasma nitrite predicts exercise capacity. Br J Sports Med 2007, 41, 669-673; discussion 673, doi:10.1136/bjsm.2007.035758.
  15. Del Rosso, J.Q.; Kircik, L.H. Spotlight on the Use of Nitric Oxide in Dermatology: What Is It? What Does It Do? Can It Become an Important Addition to the Therapeutic Armamentarium for Skin Disease? J Drugs Dermatol 2017, 16, s4-s10.
  16. Han, G.; Zippin, J.H.; Friedman, A. From bench to bedside: the therapeutic potential of nitric oxide in dermatology. J Drugs Dermatol 2009, 8, 586-594.
  17. Kutner, A.J.; Friedman, A.J. Use of nitric oxide nanoparticulate platform for the treatment of skin and soft tissue infections. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2013, 5, 502-514, doi:10.1002/wnan.1230.
  18. Adler, B.L.; Friedman, A.J. Nitric oxide therapy for dermatologic disease. Future Sci OA 2015, 1, FSO37, doi:10.4155/fso.15.37.
  19. Zaenglein, A.L. Acne Vulgaris. N Engl J Med 2018, 379, 1343-1352, doi:10.1056/NEJMcp1702493.
  20. Pochi, P.E.; Shalita, A.R.; Strauss, J.S.; Webster, S.B.; Cunliffe, W.J.; Katz, H.I.; Kligman, A.M.; Leyden, J.J.; Lookingbill, D.P.; Plewig, G., et al. Report of the Consensus Conference on Acne Classification. Washington, D.C., March 24 and 25, 1990. J Am Acad Dermatol 1991, 24, 495-500, doi:10.1016/s0190-9622(08)80076-x.
  21. Adityan, B.; Kumari, R.; Thappa, D.M. Scoring systems in acne vulgaris. Indian J Dermatol Venereol Leprol 2009, 75, 323-326, doi:10.4103/0378-6323.51258.
  22. Hyun, E.; Bolla, M.; Steinhoff, M.; Wallace, J.L.; Soldato, P.D.; Vergnolle, N. Anti-inflammatory effects of nitric oxide-releasing hydrocortisone NCX 1022, in a murine model of contact dermatitis. Br J Pharmacol 2004, 143, 618-625, doi:10.1038/sj.bjp.0705854.
  23. Baldwin, H.; Blanco, D.; McKeever, C.; Paz, N.; Vasquez, Y.N.; Quiring, J.; Enloe, C.; De Leon, E.; Stasko, N. Results of a Phase 2 Efficacy and Safety Study with SB204, an Investigational Topical Nitric Oxide-releasing Drug for the Treatment of Acne Vulgaris. J Clin Aesthet Dermatol 2016, 9, 12-18.
  24. Halvorsen, J.A.; Vleugels, R.A.; Bjertness, E.; Lien, L. A population-based study of acne and body mass index in adolescents. Arch Dermatol 2012, 148, 131-132, doi:10.1001/archderm.148.1.131.
  25. Garofalo, V.; Cannizzaro, M.V.; Mazzilli, S.; Bianchi, L.; Campione, E. Clinical evidence on the efficacy and tolerability of a topical medical device containing benzoylperoxide 4%, retinol 0.5%, mandelic acid 1% and lactobionic acid 1% in the treatment of mild facial acne: an open label pilot study. Clin Cosmet Investig Dermatol 2019, 12, 363-369, doi:10.2147/CCID.S182317.
  26. Tsai, M.C.; Chen, W.; Cheng, Y.W.; Wang, C.Y.; Chen, G.Y.; Hsu, T.J. Higher body mass index is a significant risk factor for acne formation in schoolchildren. Eur J Dermatol 2006, 16, 251-253.
  27. Finlay, A.Y.; Khan, G.K. Dermatology Life Quality Index (DLQI)–a simple practical measure for routine clinical use. Clin Exp Dermatol 1994, 19, 210-216, doi:10.1111/j.1365-2230.1994.tb01167.x.
  28. Zaenglein, A.L.; Pathy, A.L.; Schlosser, B.J.; Alikhan, A.; Baldwin, H.E.; Berson, D.S.; Bowe, W.P.; Graber, E.M.; Harper, J.C.; Kang, S., et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol 2016, 74, 945-973 e933, doi:10.1016/j.jaad.2015.12.037.
  29. Aslam, I.; Fleischer, A.; Feldman, S. Emerging drugs for the treatment of acne. Expert Opin Emerg Drugs 2015, 20, 91-101, doi:10.1517/14728214.2015.990373.
  30. Hernandez-Cuellar, E.; Tsuchiya, K.; Hara, H.; Fang, R.; Sakai, S.; Kawamura, I.; Akira, S.; Mitsuyama, M. Cutting edge: nitric oxide inhibits the NLRP3 inflammasome. J Immunol 2012, 189, 5113-5117, doi:10.4049/jimmunol.1202479.
  31. Kim, M.; Yin, J.; Hwang, I.H.; Park, D.H.; Lee, E.K.; Kim, M.J.; Lee, M.W. Anti-Acne Vulgaris Effects of Pedunculagin from the Leaves of Quercus mongolica by Anti-Inflammatory Activity and 5alpha-Reductase Inhibition. Molecules 2020, 25, doi:10.3390/molecules25092154.
  32. Qin, M.; Landriscina, A.; Rosen, J.M.; Wei, G.; Kao, S.; Olcott, W.; Agak, G.W.; Paz, K.B.; Bonventre, J.; Clendaniel, A., et al. Nitric Oxide-Releasing Nanoparticles Prevent Propionibacterium acnes-Induced Inflammation by Both Clearing the Organism and Inhibiting Microbial Stimulation of the Innate Immune Response. J Invest Dermatol 2015, 135, 2723-2731, doi:10.1038/jid.2015.277.
  33. Jariashvili, K.; Madhan, B.; Brodsky, B.; Kuchava, A.; Namicheishvili, L.; Metreveli, N. UV damage of collagen: insights from model collagen peptides. Biopolymers 2012, 97, 189-198, doi:10.1002/bip.21725.
  34. Settelmeier, S.; Rassaf, T.; Hendgen-Cotta, U.B., Stoffels, I. Nitric Oxide Generating Formulation as an Innovative Approach to Topical Skin Care: An Open-Label Pilot Study. Cosmetics 2021, 8, 16. https://doi.org/ 10.3390/cosmetics8010016